As an example, IL-2 doses of 9–12 × 106 units daily may downregulate CYP activities in patients with HIV infection and cancer in whom this treatment is administered to boost the immune system (Piscitelli et al., 1998; Elkahwaji et al., 1999). Here, PPIG is linked to cancer.